Several antibody therapies used against Covid-19 earlier in the pandemic are no longer available because the virus has evolved and they are no longer effective.
The "tripledemic" of flu, COVID-19, and RSV cases are on the rise this holiday season, leaving many wondering which virus they've caught. Here's how to tell the difference:
US officials have warned for months that the antibody therapy was not working against certain emerging variants, but it was still available. CNN had previously reported that many patients who used the medication weren't aware the medication was no longer as effective as it once was, and continued to rely on it for protection against COVID-19.
Data has shown Evusheld is unlikely to work against XBB, XBB.1.5, BQ.1 and BQ.1.1; combined, these variants are estimated to be causing nearly 93% of new US COVID-19 cases.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
FDA halts authorization of Evusheld, citing medication insufficient against viral COVID-19 variantsSeveral antibody therapies used against Covid-19 earlier in the pandemic are no longer available because the virus has evolved and they are no longer effective.
続きを読む »
With rise of new coronavirus variants, FDA halts authorization of Evusheld | CNNThe US Food and Drug Administration on Thursday halted the emergency use authorization of Evusheld because it does not appear to protect against Covid-19 from viral variants currently circulating in the United States.
続きを読む »
FDA Wants Annual COVID Boosters, Just Like Annual Flu ShotsHealth officials want to simplify the recommended COVID-19 vaccine protocol, making it more like the process for annual flu shots.
続きを読む »
The FDA Wants an Annual COVID Vaccine: What You Need to KnowA national advisory committee is expected to vote Thursday on whether Americans should pivot to an annual COVID-19 shot (like a flu shot) vs. periodic booster shots. WebMD asks health experts your most pressing questions about a possible switch to a yearly shot.
続きを読む »
The FDA Considers New Plan of Administering COVID-19 VaccinesThe Food and Drug Administration is considering a shift to a new way of administering the COVID-19 vaccine that is akin to receiving the flu shot. The FDA’s vaccine advisory committee will meet Thursday to discuss this proposed change, as well as other updates concerning the status of current and...
続きを読む »